Friday, December 23, 2022

Cellectis Announces First Dosing of a Patient with its - GlobeNewswire

... an end-to-end cell and gene therapy company, from discovery & product development, transfer, and cGMP manufacturing to clinical development.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...